FK506 enhances fibrogenesis in in vitro and in vivo models of liver fibrosis in rats

Gastroenterology
E FrizellM A Zern

Abstract

The immunosuppressant FK506 is undergoing clinical trials in transplantation and autoimmune diseases. FK506 modulates several cytokines and exerts hepatoprotection in acute models. This study was initiated to determine whether FK506 would be beneficial as an antifibrogenic agent. Fibrosis was induced by carbon tetrachloride administration to rats. Half of those animals were treated with FK506. The rats were killed after 8 weeks of carbon tetrachloride treatment. The livers were evaluated by histology, Northern hybridizations, and collagen quantitation. Additionally, rat fibroblasts were incubated with and without FK506 and used for Northern hybridization analysis. Surprisingly, FK506 exacerbated hepatic inflammation and fibrosis. Increased hepatic collagen and higher messenger RNA levels of transforming growth factor beta 1 and collagens I, III, and IV were found in the FK506-treated group. Rat fibroblasts treated with FK506 expressed higher levels of collagens I and III, fibronectin, macrophage-colony stimulating factor, tissue inhibitor of metalloprotease, and transforming growth factor beta 1 messenger RNAs. These findings suggest that FK506 increases the expression of extracellular matrix genes and enhances fibrosis in the ...Continue Reading

Citations

Jan 9, 1998·Transplantation·F S ShihabT F Andoh
Sep 4, 1998·Pediatric Research·J N RosensweigK B Schwarz
Oct 31, 2003·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Geoffrey W McCaughan, Amany Zekry
Sep 16, 2004·Journal of Clinical Periodontology·J S EllisJ M Thomason
Sep 13, 2008·Transplant International : Official Journal of the European Society for Organ Transplantation·Georgios KalambokisAndrew K Burroughs
Jul 29, 1998·Transplantation·S Sanchez-CamposJ Gonzalez-Gallego
Oct 3, 2002·Seminars in Dialysis·Nasimul Ahsan, K Venkateswara Rao

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Hepatitis

Autoimmune hepatitis formerly called lupoid hepatitis, is a chronic, autoimmune disease of the liver that occurs when the body's immune system attacks liver cells causing the liver to be inflamed. Discover the latest research on autoimmune hepatitis here.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.